ATE323085T1 - Heterozyclische verbindungen mit affinität für den ht1 rezeptor und ihre therapeutische verwendung - Google Patents
Heterozyclische verbindungen mit affinität für den ht1 rezeptor und ihre therapeutische verwendungInfo
- Publication number
- ATE323085T1 ATE323085T1 AT03708113T AT03708113T ATE323085T1 AT E323085 T1 ATE323085 T1 AT E323085T1 AT 03708113 T AT03708113 T AT 03708113T AT 03708113 T AT03708113 T AT 03708113T AT E323085 T1 ATE323085 T1 AT E323085T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- alkyl
- carbon
- hydrogen
- compounds
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 229910052799 carbon Inorganic materials 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- 125000001589 carboacyl group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000003341 7 membered heterocyclic group Chemical group 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- -1 oxo-substituted carbon atom Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0203804.0A GB0203804D0 (en) | 2002-02-18 | 2002-02-18 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE323085T1 true ATE323085T1 (de) | 2006-04-15 |
Family
ID=9931290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03708113T ATE323085T1 (de) | 2002-02-18 | 2003-02-17 | Heterozyclische verbindungen mit affinität für den ht1 rezeptor und ihre therapeutische verwendung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7244726B2 (de) |
| EP (1) | EP1476444B1 (de) |
| JP (1) | JP2005527500A (de) |
| AT (1) | ATE323085T1 (de) |
| AU (1) | AU2003212254A1 (de) |
| DE (1) | DE60304559T2 (de) |
| ES (1) | ES2259759T3 (de) |
| GB (1) | GB0203804D0 (de) |
| WO (1) | WO2003068772A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| GB0310851D0 (en) * | 2003-05-12 | 2003-06-18 | Glaxo Group Ltd | Compounds |
| GB0316915D0 (en) | 2003-07-18 | 2003-08-20 | Glaxo Group Ltd | Compounds |
| JP4533391B2 (ja) * | 2004-01-16 | 2010-09-01 | エフ．ホフマン−ラ ロシュ アーゲー | 中枢神経系疾患の処置のための５−ヒドロキシトリプタミンレセプター（５−ｈｔ）のモジュレーターとしての、１−ベンジル−５−ピペラジン−１−イル−３，４−ジヒドロ−１ｈ−キナゾリン−２−オン誘導体、ならびにそれぞれの１ｈ−ベンゾ（１，２，６）チアジアジン−２，２−ジオキシドおよび１，４−ジヒドロベンゾ（ｄ）（１，３）オキサジン−２−オン誘導体 |
| DE102004010132A1 (de) * | 2004-02-27 | 2005-09-15 | Merck Patent Gmbh | Piperidinderivate |
| US8235964B2 (en) * | 2006-04-25 | 2012-08-07 | Sca Hygiene Products Ab | Pant-like absorbent article and a method for making it |
| US10752588B2 (en) | 2014-12-19 | 2020-08-25 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
| WO2016100940A1 (en) | 2014-12-19 | 2016-06-23 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
| CN114573555B (zh) * | 2020-11-30 | 2026-02-17 | 上海天慈国际药业有限公司 | 一种用于治疗偏头痛的化合物的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9407447D0 (en) | 1994-04-14 | 1994-06-08 | Glaxo Group Ltd | Chemical compounds |
| KR20000016151A (ko) * | 1996-05-29 | 2000-03-25 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 벤족사지논 도파민 d4 수용체 길항제 |
| EP0900792B1 (de) * | 1997-09-02 | 2003-10-29 | Duphar International Research B.V | Piperidin- und Piperazin Derivate als 5-HT1-Rezeptor-Agonisten |
| JP2002510682A (ja) * | 1998-04-08 | 2002-04-09 | アメリカン・ホーム・プロダクツ・コーポレイション | うつ病治療用のインドール−３−イル−シクロヘキシルアミン誘導体（５−ｈｔ１受容体拮抗薬） |
| AU2494300A (en) * | 1999-01-07 | 2000-07-24 | American Home Products Corporation | 3,4-dihydro-2h-benzo(1,4)oxazine derivatives |
| CN1478092A (zh) | 2000-10-26 | 2004-02-25 | ʷ | 苯并噁嗪酮衍生物及其制备和应用 |
-
2002
- 2002-02-18 GB GBGB0203804.0A patent/GB0203804D0/en not_active Ceased
-
2003
- 2003-02-17 AU AU2003212254A patent/AU2003212254A1/en not_active Abandoned
- 2003-02-17 ES ES03708113T patent/ES2259759T3/es not_active Expired - Lifetime
- 2003-02-17 DE DE60304559T patent/DE60304559T2/de not_active Expired - Fee Related
- 2003-02-17 EP EP03708113A patent/EP1476444B1/de not_active Expired - Lifetime
- 2003-02-17 US US10/504,109 patent/US7244726B2/en not_active Expired - Fee Related
- 2003-02-17 AT AT03708113T patent/ATE323085T1/de not_active IP Right Cessation
- 2003-02-17 WO PCT/EP2003/001711 patent/WO2003068772A1/en not_active Ceased
- 2003-02-17 JP JP2003567899A patent/JP2005527500A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003068772A1 (en) | 2003-08-21 |
| AU2003212254A1 (en) | 2003-09-04 |
| US7244726B2 (en) | 2007-07-17 |
| JP2005527500A (ja) | 2005-09-15 |
| EP1476444B1 (de) | 2006-04-12 |
| ES2259759T3 (es) | 2006-10-16 |
| EP1476444A1 (de) | 2004-11-17 |
| GB0203804D0 (en) | 2002-04-03 |
| DE60304559T2 (de) | 2007-04-05 |
| US20050085458A1 (en) | 2005-04-21 |
| DE60304559D1 (de) | 2006-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL91417A0 (en) | Antidepressant n-substituted nicotinamide compounds | |
| JP2005509622A5 (de) | ||
| DE69110320D1 (de) | Stickstoff enthaltende heterozyklische Verbindungen, ihre Herstellung und Verwendung. | |
| JP2005511532A5 (de) | ||
| ATE293101T1 (de) | Piperidine zur verwendung als orexin rezeptor antagonisten | |
| JP2004516293A5 (de) | ||
| ATE325110T1 (de) | Sauerstoff enthaltende heterocyclische verbindungen | |
| CA2045955A1 (en) | Indole derivatives | |
| TNSN06203A1 (en) | Derivatives of n- (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity | |
| ATE380818T1 (de) | Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose | |
| DE60304559D1 (de) | Heterozyclische verbindungen mit affinität für den ht1 rezeptor und ihre therapeutische verwendung | |
| CA2207784A1 (en) | Certain pyrrolopyridine derivatives; novel crf1 specific ligands | |
| CO5251458A1 (es) | Nuevos compuestos | |
| HUP0001165A2 (hu) | NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra | |
| HUP0203622A2 (hu) | Biciklusos vazopresszin agonisták és ezeket tartalmazó gyógyszerkészítmények | |
| MXPA02011464A (es) | Derivados 1,4-diazepan-2,5-diona y su uso como antagonistas del receptor de la nk-1. | |
| ATE359282T1 (de) | Verbindungen mit affinität zu rezeptoren des 5ht- 1-typs und deren verwendung in der therapie von erkrankungen des zns | |
| ATE102626T1 (de) | Heterocyclische verbindungen, ihre darstellung und verwendung. | |
| ATE259359T1 (de) | Benzoxazol-derivate zur verwendung als integrin- inhibitoren | |
| EA199900043A1 (ru) | ПРОИЗВОДНЫЕ ПИРИДИЛКАРБАМОИЛИНДОЛИНОВ В КАЧЕСТВЕ АНТАГОНИСТОВ 5-НТ2с-РЕЦЕПТОРОВ | |
| PT1776339E (pt) | Derivados de 3-(((4-fenil)-piperazin-1-il)-alquil)-3-alquil- 1,3-di-hidro-2h-indol-2-ona e compostos relacionados para o tratamento de desordens do sistema nervoso central | |
| HRP20080501T3 (en) | Beta-lactams for the treatment of cns disorders | |
| ATE375353T1 (de) | Thienopyridoncarbonsäureamide und deren medizinische verwendung | |
| ES2162731B1 (es) | Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas. | |
| TW351717B (en) | Pyenyl-substituted cyclic ketoenols |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |